Skip to main content

Table 2 Monthly CLA-BSI during the study period, device utilization ratio and organismscausing CLA-BSI in each month.

From: Beyond the bundle - journey of a tertiary care medical intensive care unit to zerocentral line-associated bloodstream infections

Surveillance period Number of CLA-BSI Central line days CLA-BSI rate/1000 central line days Patient days Device utilization ratio Organisms causing CLA-BSI
Jan-08 1 550 1.82 700 0.79 VRE faecium
Feb-08 2 547 3.66 675 0.81 Acinetobacter baumannii
Methicillin-resistant Staphylococcus epidermidis
Mar-08 3 562 5.34 739 0.76 Enterococcus faecium
Methicillin-resistant Staphylococcus epidermidis
Candida parapsilosis
Apr-08 1 470 2.13 661 0.71 Group B Streptococcus agalactiae
May-08 1 468 2.14 668 0.70 Methicillin-resistant Staphylococcus epidermidis
Jun-08 1 478 2.09 629 0.76 Enterobacter cloacae
Jul-08 0 351 0.00 626 0.56  
Aug-08 1 340 2.94 683 0.50 Klebsiella oxytoca
Sep-08 0 360 0.00 649 0.55  
Oct-08 0 510 0.00 691 0.74  
Nov-08 1 518 1.93 696 0.74 Pseudomonas aeruginosa
Dec-08 2 514 3.89 699 0.74 Klebsiella pneumoniae
Methicillin-resistant Staphylococcus epidermidis
Jan-09 2 461 4.34 700 0.66 Prevotella buccae and Achromobacter xylosoxidans
Feb-09 1 474 2.11 634 0.75 Candida glabrata
Mar-09 4 568 7.04 721 0.79 Pseudomonas fluorescans, Peptostreptococcus, VREfaecium
Apr-09 0 417 0.00 639 0.65  
May-09 1 394 2.54 644 0.61 Candida albicans, VRE faecium
Jun-09 0 358 0.00 626 0.57  
Jul-09 3 389 7.71 673 0.58 Candida glabrata, VRE faecium, E.coli
Aug-09 2 513 3.90 684 0.75 Acinetobacter baumannii, VRE faecium
Sep-09 0 436 0.00 661 0.66  
Oct-09 1 505 1.98 699 0.72 Pseudomonas aeruginosa
Nov-09 1 569 1.76 679 0.84 Klebsiella pneumoniae
Dec-09 2 565 3.54 728 0.78 Enterococcus faecalis, Acinetobacter baumannii
Jan-10 0 468 0.00 678 0.69  
Feb-10 0 411 0.00 626 0.66  
Mar-10 2 457 4.38 623 0.73 VRE faecium, VRE faecium
Apr-10 2 386 5.18 565 0.68 Methicillin-resistant Staphylococcus epidermidis, VREfaecium
May-10 0 480 0.00 615 0.78  
Jun-10 2 479 4.18 612 0.78 Morganella morganii, Enterobacter cloacae
Jul-10 0 468 0.00 654 0.72  
Aug-10 1 478 2.09 627 0.76 VRE faecium
Sep-10 0 423 0.00 626 0.68  
Oct-10 2 534 3.75 711 0.75 VRE faecium, VRE faecium
Nov-10 2 532 3.76 679 0.78 VRE faecium, Methicillin- resistant Staphylococcusepidermidis
Dec-10 0 473 0.00 620 0.76  
Jan-11 0 485 0.00 712 0.68  
Feb-11 1 485 2.06 647 0.75 VRE faecium
Mar-11 2 535 3.74 709 0.75 VRE faecium, Enterococcus faecalis
Apr-11 0 501 0.00 641 0.78  
May-11 0 461 0.00 677 0.68  
Jun-11 0 448 0.00 621 0.72  
Jul-11 0 351 0.00 655 0.54  
Aug-11 0 454 0.00 690 0.66  
Sep-11 0 543 0.00 705 0.77  
Oct-11 0 473 0.00 677 0.70  
Nov-11 0 473 0.00 653 0.72  
Dec-11 0 473 0.00 704 0.67  
  1. CLA-BSI, central line-associated bloodstream infections.